List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 2661 studies with search of: Open Studies | "Carcinoma"
Include studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Recruiting Study of Ramucirumab or IMC-18F1 With Docetaxel or Docetaxel Alone as Second-Line Therapy in Participants With Bladder,Urethra, Ureter, or Renal Pelvis Carcinoma
Conditions: Carcinoma of Urinary Tract;   Urethral Carcinoma;   Carcinoma of Ureter;   Carcinoma of Renal Pelvis
Interventions: Drug: Docetaxel;   Biological: Ramucirumab DP;   Biological: IMC-18F1
2 Recruiting A Trial of Photodynamic Therapy With HPPH for Treatment of Dysplasia, Carcinoma in Situ and T1 Carcinoma of the Oral Cavity and/or Oropharynx
Conditions: Dysplasia;   Carcinoma of the Oral Cavity;   Carcinoma of the Oropharynx
Intervention: Drug: HPPH
3 Not yet recruiting Trial of Chemotherapy in Ovarian, Fallopian Tube and Peritoneal Carcinoma
Conditions: Primary Peritoneal Carcinoma;   Ovarian Carcinoma;   Fallopian Tube Carcinoma
Intervention: Drug: neoadjuvant chemotherapy
4 Recruiting First Line Pazopanib in Poor Risk Patients With Metastatic Renal Cell Carcinoma
Conditions: Locally Advanced and/or Metastatic Renal Cell Carcinoma;   Carcinoma, Renal Cell;   Clear-cell Metastatic Renal Cell Carcinoma
Intervention: Drug: Pazopanib
5 Recruiting First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma
Conditions: Transitional Cell Carcinoma;   Bladder Carcinoma;   Urothelial Carcinoma
Interventions: Drug: Everolimus;   Drug: Paclitaxel
6 Recruiting Genome-wide Association Study to Predict Treatment Response for Molecular Targeted Therapy in Hepatocellular Carcinoma and Renal Cell Carcinoma
Conditions: Hepatocellular Carcinoma;   Renal Cell Carcinoma
Intervention:
7 Recruiting Microarray Analysis of Gene Expression and Identification of Progenitor Cells in Lung Carcinoma
Conditions: Carcinoma, Giant Cell;   Carcinoma, Non-Small-Cell Lung;   Lung Cancer
Intervention:
8 Unknown † Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular Carcinoma
Conditions: Advanced Hepatocellular Carcinoma;   Metastatic Hepatocellular Carcinoma
Intervention: Drug: Sorafenib with Capecitabine and Oxaliplatin
9 Not yet recruiting ERBITUX® Followed by Adjuvant Treatment With Chemoradiation and ERBITUX® for Locally Advanced Head and Neck Squamous Cell Carcinoma
Conditions: Head Squamous Cell Carcinoma;   Neck Squamous Cell Carcinoma
Interventions: Drug: Cetuximab;   Procedure: Surgery;   Radiation: Post-surgical radiation;   Drug: Cisplatin or carboplatin
10 Recruiting Efficacy, Safety and Pharmacokinetics of Oral LDE225 in Treatment of Patients With Nevoid Basal Cell Carcinoma Syndrome
Conditions: Basal Cell Carcinoma;   Gorlin Syndrome;   Nevoid Basal Cell Carcinoma Syndrome
Interventions: Drug: LDE225;   Drug: Placebo
11 Recruiting A Phase 0 of Neoadjuvant Lapatinib in Infiltrative Bladder Carcinoma Before Cystectomy
Conditions: Bladder Carcinoma;   Infiltrative Bladder Carcinoma;   Cystectomy
Intervention: Drug: LAPATINIB
12 Recruiting L-BLP25 in Patients With Colorectal Carcinoma After Curative Resection of Hepatic Metastases
Conditions: Colon Carcinoma;   Rectum Carcinoma
Interventions: Biological: L-BLP25;   Biological: Placebo
13 Recruiting Docetaxel, Cisplatin (TP) + Radiation +/- Cetuximab in Larynx Carcinoma (CA)
Conditions: Squamous Cell Carcinoma of the Hypopharynx;   Larynx Carcinoma
Interventions: Radiation: Radiation;   Drug: Cetuximab;   Drug: Docetaxel;   Drug: Cisplatin (TP);   Drug: 5-Fluorouracil (TPF) (only until Feb 2009)
14 Recruiting Esophagoscopy in Evaluating Treatment in Patients With Stage I-IV Head and Neck Cancer Who Are Undergoing Radiation Therapy and/or Chemotherapy
Conditions: Stage I Adenoid Cystic Carcinoma of the Oral Cavity;   Stage I Mucoepidermoid Carcinoma of the Oral Cavity;   Stage I Squamous Cell Carcinoma of the Hypopharynx;   Stage I Squamous Cell Carcinoma of the Larynx;   Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage I Verrucous Carcinoma of the Larynx;   Stage I Verrucous Carcinoma of the Oral Cavity;   Stage II Adenoid Cystic Carcinoma of the Oral Cavity;   Stage II Mucoepidermoid Carcinoma of the Oral Cavity;   Stage II Squamous Cell Carcinoma of the Hypopharynx;   Stage II Squamous Cell Carcinoma of the Larynx;   Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage II Verrucous Carcinoma of the Larynx;   Stage II Verrucous Carcinoma of the Oral Cavity;   Stage III Adenoid Cystic Carcinoma of the Oral Cavity;   Stage III Mucoepidermoid Carcinoma of the Oral Cavity;   Stage III Squamous Cell Carcinoma of the Hypopharynx;   Stage III Squamous Cell Carcinoma of the Larynx;   Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage III Verrucous Carcinoma of the Larynx;   Stage III Verrucous Carcinoma of the Oral Cavity;   Stage IV Adenoid Cystic Carcinoma of the Oral Cavity;   Stage IV Mucoepidermoid Carcinoma of the Oral Cavity;   Stage IV Squamous Cell Carcinoma of the Hypopharynx;   Stage IV Squamous Cell Carcinoma of the Larynx;   Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IV Verrucous Carcinoma of the Larynx;   Stage IV Verrucous Carcinoma of the Oral Cavity
Interventions: Procedure: endoscopic procedure;   Other: questionnaire administration
15 Recruiting Phase I/II Study of Postoperative Adjuvant Chemoradiation for Advanced-Stage Cutaneous Squamous Cell Carcinoma of the Head and Neck (cSCCHN)
Conditions: Recurrent Skin Cancer;   Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity;   Squamous Cell Carcinoma of the Skin;   Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity
Interventions: Drug: erlotinib hydrochloride;   Drug: linsitinib;   Drug: placebo;   Radiation: radiation therapy;   Procedure: therapeutic conventional surgery;   Other: laboratory biomarker analysis
16 Recruiting AMG 172 First in Human Study in Patients With Kidney Cancer
Conditions: Renal Cell Adenocarcinoma;   Clear Cell Renal Carcinoma;   Clear Cell Renal Cell Carcinoma;   Renal Cell Carcinoma
Intervention: Drug: AMG 172
17 Recruiting Interleukin-12 Gene and in Vivo Electroporation-Mediated Plasmid DNA Vaccine Therapy in Treating Patients With Merkel Cell Cancer
Conditions: Recurrent Neuroendocrine Carcinoma of the Skin;   Stage I Neuroendocrine Carcinoma of the Skin;   Stage II Neuroendocrine Carcinoma of the Skin;   Stage III Neuroendocrine Carcinoma of the Skin;   Stage IV Neuroendocrine Carcinoma of the Skin
Interventions: Biological: interleukin-12 gene;   Biological: electroporation-mediated plasmid DNA vaccine therapy;   Other: laboratory biomarker analysis
18 Recruiting Capecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and Neck
Conditions: Head and Neck Cancer;   Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma;   Recurrent Metastatic Squamous Neck Cancer With Occult Primary;   Recurrent Salivary Gland Cancer;   Squamous Cell Carcinoma of the Hypopharynx Recurrent;   Laryngeal Squamous Cell Carcinoma Recurrent;   Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity;   Oropharyngeal Squamous Cell Carcinoma Recurrent;   Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Laryngeal Verrucous Carcinoma Recurrent;   Verrucous Carcinoma of the Oral Cavity Recurrent;   Squamous Cell Carcinoma of Salivary Gland;   Salivary Gland Cancer Stage IV;   Squamous Cell Carcinoma of the Hypopharynx Stage IV;   Laryngeal Squamous Cell Carcinoma Stage IV;   Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IV Squamous Cell Carcinoma of the Oropharynx;   Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Laryngeal Verrucous Carcinoma Stage IV;   Verrucous Carcinoma of the Oral Cavity Stage IV
Interventions: Drug: lapatinib ditosylate;   Drug: capecitabine
19 Recruiting Famitinib in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma (NPC)
Conditions: Recurrent Nasopharyngeal Carcinoma;   Metastatic Nasopharyngeal Carcinoma
Intervention: Drug: Famitinib
20 Recruiting Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Conditions: Stage III Squamous Cell Carcinoma of the Hypopharynx;   Stage III Squamous Cell Carcinoma of the Larynx;   Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage III Squamous Cell Carcinoma of the Nasopharynx;   Stage III Squamous Cell Carcinoma of the Oropharynx;   Stage IV Squamous Cell Carcinoma of the Hypopharynx;   Stage IV Squamous Cell Carcinoma of the Larynx;   Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IV Squamous Cell Carcinoma of the Nasopharynx;   Stage IV Squamous Cell Carcinoma of the Oropharynx
Interventions: Drug: erlotinib hydrochloride;   Drug: cisplatin;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy;   Procedure: quality-of-life assessment

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services